Summit Therapeutics (SMMT) Current Leases (2019 - 2025)
Historic Current Leases for Summit Therapeutics (SMMT) over the last 7 years, with Q3 2025 value amounting to $2.7 million.
- Summit Therapeutics' Current Leases fell 2827.0% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year decrease of 2827.0%. This contributed to the annual value of $3.8 million for FY2024, which is 3403.35% up from last year.
- Per Summit Therapeutics' latest filing, its Current Leases stood at $2.7 million for Q3 2025, which was down 2827.0% from $3.1 million recorded in Q2 2025.
- In the past 5 years, Summit Therapeutics' Current Leases ranged from a high of $3.8 million in Q3 2024 and a low of $684000.0 during Q2 2022
- Moreover, its 5-year median value for Current Leases was $2.7 million (2025), whereas its average is $2.3 million.
- As far as peak fluctuations go, Summit Therapeutics' Current Leases surged by 34517.85% in 2021, and later crashed by 3200.8% in 2022.
- Over the past 5 years, Summit Therapeutics' Current Leases (Quarter) stood at $1.1 million in 2021, then surged by 54.9% to $1.7 million in 2022, then skyrocketed by 66.21% to $2.8 million in 2023, then soared by 34.03% to $3.8 million in 2024, then decreased by 27.76% to $2.7 million in 2025.
- Its last three reported values are $2.7 million in Q3 2025, $3.1 million for Q2 2025, and $3.5 million during Q1 2025.